Internal Medicine, Interventional Cardiology · Boynton Beach, FL
NPI
1235138082
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
323 SE 23rd Ave
Boynton Beach, FL, 33435
Phone (561) 737-1818
Groups this clinician bills Medicare through
Medicare paid, 2024
$703K
36,997 services
Medicare patients, 2024
174
Average age 76
Drug cost, 2024
$2.7M
8,412 prescriptions
Company payments, 2025
$2,903
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adel M Sidky was code J1306 (injection, inclisiran, 1 mg), 32,660 times for 63 patients. In total Adel M Sidky billed 36,997 services in 41 codes, and Medicare paid $703K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 32,660 | 63 | $9.52 | $311K |
| 93000 Electrocardiogram | Office | 675 | 173 | $11.59 | $7,822 |
| 99214 Office E&M - Established | Office | 628 | 146 | $104.60 | $66K |
| 36415 Venipuncture Blood Collection | Office | 443 | 159 | $8.65 | $3,832 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 364 | 90 | $5.70 | $2,075 |
| 99215 Office E&M - Established | Office | 320 | 143 | $140.14 | $45K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 256 | 126 | $380.51 | $97K |
| 93306 Echocardiography (TTE/TEE) | Office | 246 | 161 | $160.61 | $40K |
| 93356 Echocardiography (TTE/TEE) | Office | 243 | 160 | $31.15 | $7,569 |
| 96372 Injection Administration | Office | 198 | 89 | $12.23 | $2,421 |
| 93015 Electrocardiogram | Office | 131 | 128 | $53.46 | $7,003 |
| 78452 Myocardial Perfusion Scan | Office | 128 | 126 | $355.14 | $45K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 94 | 54 | $0.96 | $90.65 |
| 99213 Office E&M - Established | Office | 87 | 55 | $76.17 | $6,627 |
| 93224 Electrocardiogram | Office | 73 | 61 | $53.21 | $3,885 |
By year: 2022 $442K for 5,078 services; 2023 $544K for 17,899 services; 2024 $703K for 36,997 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 443 | 159 | $8.65 | $3,832 |
Medicare prescription drug claims, 2024
In 2024, the drug Adel M Sidky prescribed most often to Medicare patients was Nebivolol Hcl, with 555 prescriptions and refills. In total Adel M Sidky wrote 8,412 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nebivolol Hcl Generic | 555 | 1,460 | 169 | $34K |
| Entresto Sacubitril/Valsartan | 431 | 750 | 107 | $481K |
| Spironolactone Generic | 399 | 1,089 | 143 | $3,647 |
| Farxiga Dapagliflozin Propanediol | 350 | 560 | 85 | $310K |
| Jardiance Empagliflozin | 331 | 664 | 97 | $378K |
| Pantoprazole Sodium Generic | 308 | 808 | 101 | $3,102 |
| Ezetimibe Generic | 303 | 865 | 109 | $9,583 |
| Xarelto Rivaroxaban | 279 | 551 | 82 | $299K |
| Metoprolol Succinate Generic | 260 | 683 | 87 | $4,138 |
| Amlodipine Besylate Generic | 259 | 729 | 97 | $1,259 |
| Levothyroxine Sodium Generic | 250 | 647 | 66 | $2,105 |
| Repatha Sureclick Evolocumab | 236 | 365 | 50 | $204K |
| Pravastatin Sodium Generic | 226 | 619 | 74 | $3,179 |
| Atorvastatin Calcium Generic | 209 | 619 | 73 | $2,023 |
| Montelukast Sodium Generic | 208 | 560 | 71 | $2,252 |
Brand drugs: 2,688 claims; generic drugs: 5,707 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adel M Sidky $2,903 ($2,903 in general payments such as food, travel and fees) from 18 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $664.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 15 | $664 |
| Amgen Inc. AMGN | 8 | $463 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $214 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $193 |
| AtriCure, Inc. ATRC | 1 | $183 |
| Abbott Laboratories ABT | 1 | $180 |
| Merck Sharp & Dohme LLC MRK | 6 | $154 |
| Esperion Therapeutics, Inc. ESPR | 8 | $151 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $126 |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $95.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.